Journals / Turkish journal of emergency medicine (Online) / 2021 / Cilt: 21 - Sayı: 1

High‑flow nasal cannula oxygen therapy in the management of acute respiratory distress syndrome secondary to opioid overdose

Pages
30–33
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

HFNCOT can recover the patient’s hypoxemia and help reduce the necessity of mechanical ventilation in patients with mild or moderate ARDS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this article, we discuss the successful treatment of acute respiratory distress syndrome (ARDS), a rare complication of opioid overdose, through high‑flow nasal cannula oxygen therapy (HFNCOT).
📊
Key Findings & Data:A 32-year-old male patient was referred to the emergency department with an ambulance due to a state of confusion following intravenous opioid intake.
💡
Conclusion & Impact:HFNCOT can recover the patient’s hypoxemia and help reduce the necessity of mechanical ventilation in patients with mild or moderate ARDS.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

In this article, we discuss the successful treatment of acute respiratory distress syndrome (ARDS), a rare complication of opioid overdose, through high‑flow nasal cannula oxygen therapy (HFNCOT). A 32-year-old male patient was referred to the emergency department with an ambulance due to a state of confusion following intravenous opioid intake. On arrival, the patient had an arterial blood pressure of 100/60 mmHg, pulse of 112 beats/min, respiratory rate of 8 breaths/min, and oxygen saturation (SpO2 ) of 75%. On neurologic examination, he had miotic and isochoric pupils, and Glasgow Coma Score was 12 (E: 3 M: 5 V: 4). Cardiac examination showed that the heart was rhythmic and tachycardic. Chest examination revealed bibasilar crackles and wheezing. Naloxone was administered to the patient, and oxygen treatment was applied through a mask. Then, HFNCOT was commenced to the patient in whom the PaO2 /FiO2 ratio in the blood gas was calculated as 141 following antidote treatment and whose chest radiograph showed bilateral infiltrations. The patient was discharged from the emergency critical care unit on the 3rd day of his hospitalization because infiltrations in his chest radiograph regressed. HFNCOT can recover the patient’s hypoxemia and help reduce the necessity of mechanical ventilation in patients with mild or moderate ARDS.

🔖

Cite This Article

GÜLEN, M., SATAR, S., YEŞİLOĞLU, Ö., AVCI, A., ACEHAN, S. (2021). High‑flow nasal cannula oxygen therapy in the management of acute respiratory distress syndrome secondary to opioid overdose. Turkish journal of emergency medicine (Online), Cilt: 21 - Sayı: 1, 30–33. https://ajindex.com/articles/417315

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ochiai R. Mechanical ventilation of acute respiratory distress syndrome. J Intensive Care 2015;3:25
  2. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: The Berlin Definition. JAMA 2012;307:2526‑33
  3. Fanelli V, Vlachou A, Ghannadian S, Simonetti U, Slutsky AS, Zhang H. Acute respiratory distress syndrome: New definition, current and future therapeutic options. J Thorac Dis 2013;5:326‑34
  4. Nishimura M. High‑flow nasal cannula oxygen therapy in adults. J Intensive Care 2015;3:15
  5. PierrakosC, KaranikolasM, ScollettaS, KaramouzosV, VelissarisD. Acute respiratory distress syndrome: Pathophysiology and therapeutic options. J Clin Med Res 2012;4:7‑16
  6. Greenberg K, Kohl B. Extracorporeal membrane oxygenation used successfully in a near fatal case of opioid‑induced acute respiratory distress syndrome. Am J Emerg Med 2018;36:343‑4
  7. Edston E, van Hage‑Hamsten M. Anaphylactoid shock – A common cause of death in heroin addicts? Allergy 1997;52:950‑4
  8. Mills CA, Flacke JW, Flacke WE, Bloor BC, Liu MD. Narcotic reversal in hypercapnic dogs: Comparison of naloxone and nalbuphine. Can J Anaesth 1990;37:238‑44
  9. Messika J, Ben Ahmed K, Gaudry S, Miguel‑Montanes R, Rafat C, Sztrymf B, et al. Use of high‑flow nasal cannula oxygen therapy in subjects with ARDS: A 1‑year observational study. Respir Care 2015;60:162‑9
  10. Kernick J, Magarey J. What is the evidence for the use of high flow nasal cannula oxygen in adult patients admitted to critical care units? A systematic review. Aust Crit Care 2010;23:53‑70
  11. Rittayamai N, Tscheikuna J, Praphruetkit N, Kijpinyochai S. Use of high‑flow nasal cannula for acute dyspnea and hypoxemia in the emergency department. Respir Care 2015;60:1377‑82
  12. Parke RL, Eccleston ML, McGuinness SP. The effects of flow on airway pressure during nasal high‑flow oxygen therapy. Respir Care 2011;56:1151‑5
  13. Jones PG, Kamona S, Doran O, Sawtell F, Wilsher M. Randomized controlled trial of humidified high‑flow nasal oxygen for acute respiratory distress in the emergency department: The HOT‑ER study. Respir Care 2016;61:291‑9
  14. Gotera C, Díaz Lobato S, Pinto T, Winck JC. Clinical evidence on high flow oxygen therapy and active humidification in adults. Rev Port Pneumol 2013;19:217‑27
  15. Frat JP, Coudroy R, Marjanovic N, Thille AW. High‑flow nasal oxygen therapy and noninvasive ventilation in the management of acute hypoxemic respiratory